Tag: pembrolizumab

ECR 2018: Will immunotherapy revolutionise cancer care?

Evasion of the immune system is an important mechanism in the development and progression of cancers. Cancer immunotherapies are a promising class of therapeutic...

Interventional oncology should identify “unmet immunotherapy needs”

Daniel Sze, speaking at the ninth annual Symposium on Clinical Interventional Oncology (CIO; 4–5 February 2017, Hollywood, USA), noted that immunotherapy is a “huge...